Abstract:
OBJECTIVE: To analyse factors that influence the following: the square root of first CD4 cell count; which individuals are severely immunodeficient at or before the start of monitoring; progression from the date of the earlier of two consecutive CD4 counts < or = 200 x 10(6)/l (termed as CD200) to AIDS. SETTING: Scotland's HIV Immunology Laboratories and the Scottish Centre for Infection and Environmental Health. PATIENTS: A total of 1679 adult HIV patients in Scotland to 31 December 1994 who had ever had a CD4 cell count < or = 500 x 10(6)/l or who had developed AIDS without any immunological monitoring, of whom 912 had developed severe HIV-related immunodeficiency (i.e., were CD200/AIDS cases). RESULTS: Square-root first CD4 count was higher in women (by 2.1; SE, 0.5), in injecting drug users (IDU; by 1.8; SE, 0.5) and in younger patients (by 1.5 per 10 years; SE, 0.2), but reduced by 1.5 (SE, 0.1) per calendar year of recruitment, although it was relatively higher (by 3.8; SE, 0.8) for Edinburgh patients recruited in 1993-1994: at least 30% (nine out of 28) of new Edinburgh City Hospital patients in 1993-1994 with a first CD4 count of > or = 500 x 10(6)/l had seroconverted within the past 5 years. Two-thirds of non-IDU (67%; 348 out of 517) were already severely immunodeficient at or before the start of immunological monitoring, in contrast with only 31% of IDU CD200/AIDS cases. Overall, the odds on the CD200 date also being the date of first CD4 count have increased in recent times [log(e)(odds per calendar year of CD200 diagnosis), 0.14; SE, 0.05]. Analysis excluding patients whose AIDS diagnosis or follow-up time was within 1 month of the CD200/AIDS date supported a modest prolongation of the CD200/AIDS to AIDS interval for patients diagnosed with severe HIV-related immunodeficiency in the period 1989-1991 (log(e)[relative risk RR)], -0.46; SE, 0.22). Similarly, year effects were evident on progression from CD500 to CD200/AIDS [log(e)(RR), -0.55; SE, 0.17) for CD500 cases diagnosed in 1989, and these year effects doubled in 1990-1992. CONCLUSIONS: Minimal CD4 data were hypothesis-generating about region, risk group and calendar year. Lower bound for recent HIV incidence can be derived from new patients with first CD4 cell count above 500 x 10(6)/l if seroconversion intervals are available for a proportion.
Keywords: *Acquired Immunodeficiency Syndrome/IMMUNOLOGY *Antigens, CD4/ANALYSIS 980130
M9811067
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.
